GlassScriptPhysician profile
Jorge L Pardo
NPI 1174658348
$33,390.39
in general payments reported to CMS, 2019-2025
77 companies · $5,285 in 2025
The $5,285 reported for 2025 was more than what 85% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,463 · 2020: $2,716 · 2021: $3,529 · 2022: $4,829 · 2023: $6,327 · 2024: $6,241 · 2025: $5,285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18K · Education: $18.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17,834.32 |
| Education | $18.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $5,298.57 | 2021-2025 | |
| Ucb, INC. | $2,174.35 | 2019-2025 | Briviact, Rystiggo, Nayzilam |
| Alexion Pharmaceuticals, INC. | $1,535.40 | 2019-2025 | Ultomiris |
| Lilly USA, LLC | $1,459.48 | 2019-2025 | Kisunla, Emgality, Amyvid |
| Teva Pharmaceuticals USA, INC. | $1,418.90 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Amgen INC. | $1,402.20 | 2019-2025 | Uplizna |
| Neurocrine Biosciences, INC. | $1,227.90 | 2020-2025 | Ingrezza, Ongentys |
| Biogen, INC. | $1,189.52 | 2019-2023 | Vumerity |
| Pfizer INC. | $1,141.50 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $1,043.51 | 2019-2025 | |
| Allergan, INC. | $885.70 | 2019-2022 | |
| Lundbeck LLC | $844.14 | 2022-2025 | Vyepti, Rexulti |
| Acadia Pharmaceuticals INC | $820.53 | 2019-2025 | Nuplazid |
| Argenx US, INC. | $813.97 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Eisai INC. | $770.39 | 2019-2025 |
Show all 77 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $701.84 | 2022-2025 | Ztlido |
| Neurelis, INC. | $649.09 | 2020-2025 | Valtoco |
| Sk Life Science, INC. | $533.23 | 2020-2025 | |
| Mdd US Operations, LLC | $450.47 | 2019-2025 | Apokyn |
| Amneal Pharmaceuticals LLC | $441.66 | 2021-2025 | Rytary, Crexont, Ongentys |
| Merz Pharmaceuticals, LLC | $416.16 | 2023-2025 | Xeomin, Inbrija, Ampyra |
| Otsuka America Pharmaceutical, INC. | $415.21 | 2023-2025 | Rexulti, Nuedexta |
| Adamas Pharmaceuticals, INC. | $414.43 | 2019-2021 | |
| Impel Pharmaceuticals INC. | $382.75 | 2022-2023 | Trudhesa |
| Janssen Biotech, INC. | $373.10 | 2025 | |
| Avanir Pharmaceuticals, INC. | $368.08 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $357.29 | 2019-2022 | |
| Genzyme Corporation | $343.98 | 2019-2022 | |
| Csl Behring | $338.65 | 2019-2023 | Hizentra |
| Acorda Therapeutics, INC | $329.75 | 2019-2024 | Inbrija, Ampyra |
| Tanabe Pharma America, INC. | $274.66 | 2019-2025 | Radicava |
| Biohaven Pharmaceutical Holding Company LTD. | $269.27 | 2022 | |
| Supernus Pharmaceuticals, INC. | $240.85 | 2019-2022 | |
| Alnylam Pharmaceuticals INC. | $240.37 | 2019-2023 | Onpattro |
| Kyowa Kirin, INC. | $236.58 | 2019-2024 | Nourianz |
| Zyla Life Sciences, INC. | $198.23 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $193.92 | 2022-2025 | Wainua |
| Biohaven Pharmaceuticals, INC. | $190.65 | 2021 | |
| Almatica Pharma LLC | $180.72 | 2021-2023 | Gralise, Loreev Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $179.39 | 2023-2025 | Hyqvia, Gammagard |
| Emd Serono, INC. | $165.97 | 2019-2023 | Mavenclad |
| Ge Healthcare | $163.80 | 2019-2025 | |
| Upsher-Smith Laboratories LLC | $162.29 | 2019-2022 | |
| Corium, LLC | $157.61 | 2022-2025 | Adlarity, Azstarys |
| Idorsia Pharmaceuticals US INC | $148.71 | 2022-2024 | Quviviq |
| Akcea Therapeutics, INC. | $148.11 | 2019-2020 | |
| Microvention, INC. | $133.08 | 2025 | Web Aneurysm Embolization System |
| Azurity Pharmaceuticals, INC. | $131.49 | 2023-2024 | Horizant, Horizant |
| Averitas Pharma INC. | $126.89 | 2023-2025 | Qutenza |
| Boston Scientific Corporation | $124.15 | 2019-2025 | Watchman Flx |
| Avion Pharmaceuticals | $111.07 | 2022-2023 | Dhivy |
| Axsome Therapeutics, INC. | $97.87 | 2025 | Symbravo |
| Harmony Biosciences LLC | $92.92 | 2023 | Wakix |
| Alfasigma USA, INC. | $81.26 | 2021-2022 | |
| Grt US Holding, INC. | $75.22 | 2020-2022 | |
| Mallinckrodt Hospital Products INC. | $67.59 | 2022-2023 | Acthar |
| Livanova USA, INC. | $59.18 | 2019-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Aprecia Pharmaceuticals, LLC | $50.09 | 2022 | |
| Inspire Medical Systems, INC. | $48.89 | 2024 | Inspire |
| Assertio Therapeutics, INC. | $47.51 | 2019-2020 | |
| Insightec,INC | $44.23 | 2023-2025 | Exablate |
| Shire North American Group INC | $38.30 | 2019 | |
| Catalyst Pharmaceuticals, INC. | $35.11 | 2024 | |
| Ani Pharmaceuticals, INC. | $34.62 | 2023 | Purified Cortrophin Gel |
| Celgene Corporation | $33.96 | 2025 | Zeposia |
| Currax Pharmaceuticals LLC | $29.08 | 2020 | |
| Life Molecular Imaging LTD | $26.93 | 2019-2023 | Neuraceq |
| Sumitomo Pharma America, INC. | $23.35 | 2023 | Aptiom |
| Vanda Pharmaceuticals INC. | $23.25 | 2024 | Ponvory |
| Aquestive Therapeutics, INC. | $23.24 | 2021 | |
| Arbor Pharmaceuticals, INC. | $22.94 | 2022 | |
| Merck Sharp & Dohme LLC | $21.72 | 2025 | Welireg |
| Springworks Therapeutics, INC. | $21.40 | 2025 | Gomekli |
| Horizon Therapeutics Plc | $20.83 | 2022 | |
| Tris Pharma INC | $18.08 | 2025 | Dyanavel Xr |
| Banner Life Sciences, LLC | $17.01 | 2023 | |
| Promius Pharma LLC | $16.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Pardo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.